Accelerating Breakthroughs in Immunodermatology Drug Development
R&D
The Dermatology Drug Development Summit Europe returns for its 6th year as the premier industry forum dedicated to advancing next generation immunodermatology therapies.
Join industry pioneers from dermatology leaders like Sanofi, UCB, Kywoa Kirin and many more to ensure 2025 breaks new records!
Why do you need to attend in 2025?
- Develop Competitive Indication Expansion Strategies by leveraging mechanistic insights into disease biology and cross-indication clinical approaches.
- Explore Late-Breaking Treatment Data with exclusive presentations from PinCell and Sanofi.
- Rethink Clinical Endpoints to align with global regulatory authorities, including a deep-dive C-level panel tackling HS clinical endpoint challenges.
- Meet 80+ Industry Leaders & Peers from large pharma, scaling biotechs, academia, diagnostics, and more.
- Accelerate Collaboration Opportunities through targeted networking and interactive roundtable sessions.
Download the 2025 Event Guide here: https://ter.li/fx7pwc
Collaborate with peers to accelerate trial timelines, optimize endpoint strategies, and enhance clinical data quality to fast-track regulatory approval.
Why book on alone when you can bring a colleague?
Bring your team and save up to 20% extra off your ticket – save your place now: https://ter.li/rnhs84
